SEC Tracker
Get the app

Jasper Therapeutics JSPR

Jasper Therapeutics to hold virtual meeting

Proxy statement

Form
DEF 14A
Filed
Importance
Routine
  1. Special meeting on November 13, 2026
  2. Approval of share issuance from preferred stock conversion
  3. Ratify Patrick Crutcher as board member

Written from the DEF 14A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Jasper Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Inovio Pharmaceuticals INO public float $74M, Jun 30, 2025
  2. Macrogenics MGNX public float $74M, Jun 30, 2025
  3. Volitionrx VNRX public float $73M, Jun 30, 2025
  4. XBiotech XBIT public float $77M, Jun 30, 2025
  5. Gyre Therapeutics GYRE public float $73M, Jun 30, 2025